Quarterly report · Q2
4579.TEDINET S100P169
Period2022-01-01 → 2022-06-30
Filed2022-08-15
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Operating income | ¥551m | 2022-01-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥315m | 2021-01-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥681m | 2022-01-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥864m | 2021-01-01 → 2021-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥433m | 2021-01-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥677m | 2022-01-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥436m | 2021-01-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥469m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥756m | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥303m | 2021-01-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥469m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥303m | 2021-01-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥5.9bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥5.2bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥4.8bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥678m | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥446m | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥5.3bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥4.8bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥4.3bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.2bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.3bn | at 2021-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.8bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.1bn | at 2021-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.1bn | at 2020-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥610m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥366m | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥368m | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥92m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥279m | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥373m | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥16m | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥6m | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥22.4 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.16 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥36.07 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.45 | 2021-01-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.45 | 2021-04-01 → 2021-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥22.39 | 2022-01-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥36.04 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥14.45 | 2021-01-01 → 2021-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 88.4% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.3% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.8% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 485
| Item | Context | Value | Unit |
|---|---|---|---|
| Proceeds from long term loans payable fin cf | Prior1YTDDuration | － | JPY |
| Proceeds from long term loans payable fin cf | CurrentYTDDuration | 13100000 | JPY |
| Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cf | Prior1YTDDuration | － | JPY |
| Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cf | CurrentYTDDuration | 2275000 | JPY |
| Repayments of lease obligations fin cf | Prior1YTDDuration | -5953000 | JPY |
| Repayments of lease obligations fin cf | CurrentYTDDuration | -16816000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -5953000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -1441000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 82132000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | 88272000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 71925000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 604527000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 2061316000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 2240661000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 2133241000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 2845188000 | JPY |
| Salaries and allowances sga | Prior1YTDDuration | 77500000 | JPY |
| Salaries and allowances sga | CurrentYTDDuration | 65787000 | JPY |
| Business consignment expenses sga | Prior1YTDDuration | 104390000 | JPY |
| Business consignment expenses sga | CurrentYTDDuration | 50738000 | JPY |
| The maintenance of a patent sga | Prior1YTDDuration | 53017000 | JPY |
| The maintenance of a patent sga | CurrentYTDDuration | 30592000 | JPY |
| Depreciation sga | Prior1YTDDuration | 2629000 | JPY |
| Depreciation sga | CurrentYTDDuration | 2852000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)東海財務局長 | |
| Filing date cover page | FilingDateInstant | 2022-08-15 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第15期第２四半期（自 2022年４月１日 至 2022年６月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)ラクオリア創薬株式会社 | |
| Company name in english cover page | FilingDateInstant | RaQualia Pharma Inc. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役 武内 博文 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)愛知県名古屋市中村区名駅南一丁目21番19号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)052-446-6100（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)財務経理部長 杉山 英史 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)愛知県名古屋市中村区名駅南一丁目21番19号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)052-446-6100（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)財務経理部長 杉山 英史 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E25269 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 45790 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)ラクオリア創薬株式会社 | |
| Filer name in english | FilingDateInstant | RaQualia Pharma Inc. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |